Physician profile
David A Berg
NPI 1124286604
$870.70
in general payments reported to CMS, 2019-2025
17 companies · $195 in 2025
The $195 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $154 · 2020: $154 · 2021: $96.00 · 2023: $213 · 2024: $58.90 · 2025: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $466.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $466.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $170.64 | 2019-2025 | Surgicel Nu-Knit |
| Takeda Pharmaceuticals U.S.A., INC. | $129.87 | 2021-2025 | Gattex |
| Braintree Laboratories, INC. | $59.65 | 2021-2024 | Suflave |
| Shire North American Group INC | $56.27 | 2019 | |
| Davol INC. | $51.86 | 2020-2023 | Arista Ah Flexitip |
| Nestle Healthcare Nutrition INC. | $49.28 | 2023 | |
| Coloplast Corp | $46.55 | 2023 | Sensura Mio |
| Dentsply Ih Ab | $42.60 | 2025 | Navina Rectal Catheter Set Regular |
| Kci USA, INC. | $39.06 | 2023 | Prevena, V.A.C. Dermatac, V.A.C. Veraflo Cleanse Choice |
| Seagen INC. | $37.57 | 2020 | |
| Thd America, INC. | $37.32 | 2021-2025 | |
| Aimmune Therapeutics, INC. | $32.40 | 2025 | Zenpep |
| Smith+Nephew, INC. | $30.58 | 2021-2024 | Collagenase Santyl |
| Foundation Medicine, INC. | $29.68 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.76 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $19.98 | 2025 | V.A.C. Veraflo Cleanse Choice |
| Lilly USA, LLC | $13.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Berg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.